NCT00104793 - Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

February 28, 2007

Study Completion Date

November 30, 2008

Conditions

Lung Cancer

Interventions

DRUG

carboplatin

DRUG

irinotecan hydrochloride

Trial Locations (11)

Gunma Cancer Center, Gunma

National Hospital Organization - Dohoku National Hospital, Asahikawa

Fujisawa City Hospital, Fujisawa

Kurashiki Central Hospital, Kurashiki-shi

Osaka Kosei Nenkin Hospital, Osaka

Osaka General Medical Center, Osaka

National Hospital Organization - Osaka National Hospital, Sakai

Takatsuki Red Cross Hospital, Takatsuki

Yao Tokusyu-kai General Hospital, Yao

Tokyo Medical and Dental University, Tokyo

National Hospital Organization - Medical Center of Kure, Hiroshima

All Listed Sponsors

lead

Japan Multinational Trial Organization

OTHER